Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

18 trials with published results (10%)

Research Maturity

126 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.1%

11 terminated out of 179 trials

Success Rate

92.0%

+5.5% vs benchmark

Late-Stage Pipeline

26%

47 trials in Phase 3/4

Results Transparency

14%

18 of 126 completed with results

Key Signals

18 with results92% success11 terminated

Data Visualizations

Phase Distribution

143Total
Not Applicable (35)
Early P 1 (2)
P 1 (12)
P 2 (47)
P 3 (17)
P 4 (30)

Trial Status

Completed126
Unknown27
Terminated11
Recruiting4
Not Yet Recruiting4
Enrolling By Invitation2

Trial Success Rate

92.0%

Benchmark: 86.5%

Based on 126 completed trials

Clinical Trials (179)

Showing 20 of 20 trials
NCT02237352SuspendedPrimary

Mechanisms of Diabetic Nephropathy in Ecuador

NCT00342927Active Not RecruitingPrimary

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

NCT01105858Suspended

Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

NCT07476248Not Yet RecruitingPrimary

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

NCT03436693Phase 3CompletedPrimary

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

NCT07248891Enrolling By Invitation

Type 2 Diabetes and Associated Factors in Mexico

NCT07173686Not Yet RecruitingPrimary

Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy

NCT04981613Not ApplicableCompletedPrimary

Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy

NCT07038213Enrolling By Invitation

Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

NCT01068041Phase 2CompletedPrimary

Effects of PH3 in Diabetic Nephropathy

NCT00811889Phase 2Completed

Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT00664027Phase 2CompletedPrimary

Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nephropathy

NCT06843304RecruitingPrimary

The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy

NCT06927921Not Yet RecruitingPrimary

Assessement of the Knoweldge ,Attitudes,Practices of Diabetic Kidney Disease Among Diabetic Patients

NCT01802034Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

NCT01440257Phase 2CompletedPrimary

A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and Albuminuria

NCT01447147Phase 2CompletedPrimary

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

NCT06760845Recruiting

Raman Spectroscopy Diagnosis of Kidney Diseases

NCT06676124Not ApplicableCompleted

MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic Nephropathy

NCT06661174Recruiting

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

Scroll to load more

Research Network

Activity Timeline